B Cells in Tumor Microenvironment Associated With The Clinical Benefit to Programmed Cell Death Protein-1 Blockade Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma

JHE-CYUAN GUOHsu, Chia-LangChia-LangHsuYEN-LIN HUANGCHIA-CHI LINTA-CHEN HUANGWu, I-ChenI-ChenWuLin, Chen-YuanChen-YuanLinLien, Ming-YuMing-YuLienHUNG-YANG KUOANN-LII CHENGCHIH-HUNG HSU2022-11-072022-11-072022-062234-943Xhttps://scholars.lib.ntu.edu.tw/handle/123456789/624448B cells and B cell-related gene signatures in the tumor microenvironment (TME) are associated with the efficacy of anti-programmed cell death-1 (anti-PD-1) therapy in several cancer types, but not known for esophageal squamous cell carcinoma (ESCC).enB cell; efficacy; esophageal squamous cell carcinoma; immune checkpoint inhibitor; prognosis[SDGs]SDG3B Cells in Tumor Microenvironment Associated With The Clinical Benefit to Programmed Cell Death Protein-1 Blockade Therapy in Patients With Advanced Esophageal Squamous Cell Carcinomajournal article10.3389/fonc.2022.879398358478922-s2.0-85134179128WOS:000826967800001https://scholars.lib.ntu.edu.tw/handle/123456789/617258